PMC Links for Books (Select 4862124) - PMC

Select item 63941101.

Hyperbilirubinemia in pazopanib- or sunitinib-treated patients in COMPARZ is associated with UGT1A1 polymorphisms

R. J. Motzer, T. Johnson, T. K. Choueiri, K. C. Deen, Z. Xue, L. N. Pandite, C. Carpenter, C. F. Xu

Ann Oncol. 2013 Nov; 24(11): 2927–2928. Published online 2013 Oct 9. doi: 10.1093/annonc/mdt394

PMCID:: PMC6394110

Select item 50106032.

Occurrence of hepatotoxicity with pazopanib and other anti-VEGF treatments for renal cell carcinoma: an observational study utilizing a distributed database network

Sumitra Shantakumar, Beth L. Nordstrom, Luc Djousse, Susan A. Hall, David R. Gagnon, Kathy H. Fraeman, Myrthe van Herk-Sukel, Karen Chagin, Jeanenne Nelson

Cancer Chemother Pharmacol. 2016; 78(3): 559–566. Published online 2016 Jul 20. doi: 10.1007/s00280-016-3112-9

PMCID:: PMC5010603

Abstract Article PDF–411K

Select item 47854123.

Lethal acute liver failure in a patient treated with sunitinib

S S Guillen, M Meijer, F E de Jongh

BMJ Case Rep. 2016; 2016: bcr2015213624. Published online 2016 Mar 1. doi: 10.1136/bcr-2015-213624

PMCID:: PMC4785412

Abstract Article PDF–382K

Select item 46221694.

Safety, efficacy and prognostic analyses of sunitinib in the post-marketing surveillance study of Japanese patients with gastrointestinal stromal tumor

Yoshito Komatsu, Emiko Ohki, Naomi Ueno, Ai Yoshida, Yasuharu Toyoshima, Eiji Ueda, Hiroyuki Houzawa, Kanae Togo, Toshirou Nishida

Jpn J Clin Oncol. 2015 Nov; 45(11): 1016–1022. Published online 2015 Sep 15. doi: 10.1093/jjco/hyv126

PMCID:: PMC4622169

Abstract Article PDF–338K

Select item 44462355.

Features and Outcomes of 899 Patients with Drug-induced Liver Injury: The DILIN Prospective Study

N Chalasani, HL Bonkovsky, R Fontana, W Lee, A Stolz, J Talwalkar, KR Reddy, PB Watkins, V Navarro, H Barnhart, J Gu, J Serrano, for the United States Drug Induced Liver Injury Network

Gastroenterology. Author manuscript; available in PMC 2016 Jun 1.

Published in final edited form as: Gastroenterology. 2015 Jun; 148(7): 1340–1352.e7. Published online 2015 Mar 6. doi: 10.1053/j.gastro.2015.03.006

PMCID:: PMC4446235

Abstract Article PDF–546K

Select item 44444396.

Hepatotoxicity of molecular targeted therapy

Bożenna Karczmarek-Borowska, Agata Sałek-Zań

Contemp Oncol (Pozn) 2015; 19(2): 87–92. Published online 2014 Aug 29. doi: 10.5114/wo.2014.43495

PMCID:: PMC4444439

Abstract Article PDF–72K

Select item 44420007.

Clinical Outcomes of Patients with Advanced Gastrointestinal Stromal Tumors: Safety and Efficacy in a Worldwide Treatment-use Trial of Sunitinib

Peter Reichardt, Yoon-Koo Kang, Piotr Rutkowski, Jochen Schuette, Lee S Rosen, Beatrice Seddon, Suayib Yalcin, Hans Gelderblom, Charles C Williams, Jr, Elena Fumagalli, Guido Biasco, Herbert I Hurwitz, Pamela E Kaiser, Kolette Fly, Ewa Matczak, Liang Chen, Maria José Lechuga, George D Demetri

Cancer. Author manuscript; available in PMC 2015 May 24.

Published in final edited form as: Cancer. 2015 May 1; 121(9): 1405–1413. Published online 2015 Jan 13. doi: 10.1002/cncr.29220

Correction in:: Cancer. 2019 Mar 1; 125(5): 821.

PMCID:: PMC4442000

Abstract Article PDF–788K

Select item 32279268.

A Cancer and Leukemia Group B Phase II Study of Sunitinib Malate in Patients with Previously Treated Metastatic Pancreatic Adenocarcinoma (CALGB 80603)

Eileen M. O'Reilly, Donna Niedzwiecki, Margaret Hall, Donna Hollis, Tanios Bekaii-Saab, Timothy Pluard, Kathe Douglas, Ghassan K. Abou-Alfa, Hedy L. Kindler, Richard L. Schilsky, Richard M. Goldberg, for the Cancer and Leukemia Group B

Oncologist. 2010 Dec; 15(12): 1310–1319. Published online 2010 Dec 10. doi: 10.1634/theoncologist.2010-0152

PMCID:: PMC3227926

Abstract Article PDF–202K

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to:

Links from Books

Items: 8

Display Settings:

Send to:

Supplemental Content

Find related data

Recent activity